HeMemics Biotechnologies, Inc.

About:

The company develops an unique POC testing platform capable of testing antibodies, antigens and small molecule targets simultaneously.

Website: https://www.hememics.com/

Top Investors: TEDCO, AMVI Partners

Description:

Hememics Biotechnologies, Inc., a privately held biosensor company located in Gaithersburg, Maryland, is finalizing the development of a fundamentally different testing platform that can achieve near PCR-level accuracy at lateral-flow costs and is capable of testing antibodies, antigens and small molecule targets simultaneously. This platform consists of a rugged, low-cost handheld reader and a disposable biosensor that contains up to 32 pathogens using patented desiccation technology. This rapid point-of-care tool can achieve results in less than 5 minutes. The system can be wirelessly integrated with a cloud-based data analytics back end to track emerging threats dynamically. In addition to public health, this platform can also be used in defense/military and national security applications.